Australia - englanti - Department of Health (Therapeutic Goods Administration)

gunz dental pty ltd - 38582 - bite registration device, - paste material used to record the occlusal surfaces of teeth to veiw how the upper jaw articualates with the lower jaw

Australia - englanti - Department of Health (Therapeutic Goods Administration)

durodent holdings pty ltd - 38602 - bite registration device, bite rim wax - this is a dental material (modelling wax) used to by a dentist to assess the relation of opposing jaws of patients. making bit rims

Australia - englanti - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - 38584 - bite registration device, bite rim wax, plate - for the fabrication of bite rims and for base plates used in conjuction with try-ins.

Euroopan unioni - englanti - EMA (European Medicines Agency)

roche registration ltd. - daclizumab - graft rejection; kidney transplantation - immunosuppressants - zenapax is indicated for the prophylaxis of acute organ rejection in de novo allogenic renal transplantation and is to be used concomitantly with an immunosuppressive regimen, including cyclosporine and corticosteroids in patients who are not highly immunised.

Euroopan unioni - englanti - EMA (European Medicines Agency)

celltrion healthcare hungary kft. - rituximab - lymphoma, non-hodgkin; microscopic polyangiitis; leukemia, lymphocytic, chronic, b-cell; wegener granulomatosis - antineoplastic agents - rituzena is indicated in adults for the following indications:non-hodgkin’s lymphoma (nhl)rituzena is indicated for the treatment of previously untreated patients with stage iii iv follicular lymphoma in combination with chemotherapy.rituzena monotherapy is indicated for treatment of patients with stage iii iv follicular lymphoma who are chemo resistant or are in their second or subsequent relapse after chemotherapy.rituzena is indicated for the treatment of patients with cd20 positive diffuse large b cell non hodgkin’s lymphoma in combination with chop (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy.chronic lymphocytic leukaemia (cll)rituzena in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory cll. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including rituzenaor patients refractory to previous rituzena plus chemotherapy.granulomatosis with polyangiitis and microscopic polyangiitisrituzena, in combination with glucocorticoids, is indicated for the induction of remission in adult patients with severe, active granulomatosis with polyangiitis (wegener’s) (gpa) and microscopic polyangiitis (mpa).

Uusi-Seelanti - englanti - Ministry for Primary Industries

bayer new zealand limited - ethofumesate - ethofumesate 500 g/litre - herbicide

Uusi-Seelanti - englanti - Ministry for Primary Industries

bayer new zealand limited - pyrimethanil - suspension concentrate - pyrimethanil 400 g/litre - fungicide - fungicide

Uusi-Seelanti - englanti - Ministry for Primary Industries

bayer new zealand limited - fenhexamid - suspension concentrate - fenhexamid 500 g/litre - fungicide - fungicide

Uusi-Seelanti - englanti - Ministry for Primary Industries

bayer new zealand limited - spiroxamine - emulsifiable concentrate - spiroxamine 500 g/litre - fungicide - fungicide

Uusi-Seelanti - englanti - Ministry for Primary Industries

bayer new zealand limited - spiromesifen - suspension concentrate - spiromesifen 240 g/litre - insecticide - insecticides